KCNT1 and Epileptic encephalopathy: “Until a precision therapy is developed with an improved side effect profile, thoughtful consideration of the potential benefits and risks of a trial of quinidine is reasonable in selected patients with KCNT1‐related epileptic encephalopathy. When initiating quinidine treatment in this population, we suggest a protocol‐based approach to maximize serum levels while monitoring for side effects”